These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23702003)

  • 1. Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics.
    Mbonye AK; Birungi J; Yanow S; Magnussen P
    BMC Infect Dis; 2013 May; 13():237. PubMed ID: 23702003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of anti-malarial drug treatment among pregnant women in Uganda.
    Sangaré LR; Weiss NS; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Stergachis A
    Malar J; 2011 Jun; 10():152. PubMed ID: 21645402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom-based diagnosis of malaria and its implication on antimalarial drug use in pregnancy in Central Uganda: results from a community trial.
    Mbonye AK; Magnussen P
    Int J Adolesc Med Health; 2010; 22(2):257-62. PubMed ID: 21061926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
    Al Khaja KAJ; Sequeira RP
    Malar J; 2021 Jan; 20(1):62. PubMed ID: 33485330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prevention of malaria in pregnancy in the private health sector in Uganda: implications for patient safety.
    Mbonye AK; Buregyeya E; Rutebemberwa E; Clarke SE; Lal S; Hansen KS; Magnussen P; LaRussa P
    Malar J; 2016 Apr; 15():212. PubMed ID: 27075477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study.
    Nyeko R; Otim F; Obiya EM; Abala C
    Malar J; 2023 Mar; 22(1):103. PubMed ID: 36941616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial treatment patterns among pregnant women attending antenatal care clinics in south east Nigeria and the future implications.
    Ezenduka C; Nworgu C; Godman BB; Massele A; Esimone C
    Int J Clin Pract; 2016 Dec; 70(12):1041-1048. PubMed ID: 28032428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
    Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
    Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda.
    Mbonye AK; Lal S; Cundill B; Hansen KS; Clarke S; Magnussen P
    Malar J; 2013 Apr; 12():131. PubMed ID: 23587179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
    Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
    Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of inappropriate prescription of artemisinin and anti-malarial injections to febrile outpatients, a cross-sectional analytic survey in the Greater Accra region, Ghana.
    Bonful HA; Awua AK; Adjuik M; Tsekpetse D; Adanu RMK; Nortey PA; Ankomah A; Koram KA
    Malar J; 2019 Sep; 18(1):331. PubMed ID: 31558149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
    Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
    Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi.
    Almond D; Madanitsa M; Mwapasa V; Kalilani-Phiri L; Webster J; Ter Kuile F; Paintain L
    Malar J; 2016 Nov; 15(1):574. PubMed ID: 27894353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.